| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:15:42 UTC |
|---|
| Update date | 2019-11-26 03:20:25 UTC |
|---|
| Primary ID | FDB021453 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Chemical Information |
|---|
| FooDB Name | Pectic acid |
|---|
| Description | Present in cell walls of all plant tissues. Up to 30% w/w of this polysaccharide can be isolated from orange and lemon rind. It is used in food processing as a gelling agent, stabiliser, thickener and emusifier [DFC]
Pectic acid, also known as polygalacturonic acid, is a water insoluble, transparent gelatinous acid existing in ripe fruit and some vegetables. It is a product of pectin degradation in plants, and is produced via the interaction between pectinase and pectin (the latter being common in the wine-making industry). [Wikipedia]. Pectic acid is found in many foods, some of which are cottonseed, calabash, date, and apple. |
|---|
| CAS Number | 9046-40-6 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| alpha-D-GalA-(1->4)-alpha-D-gala-(1->4)-alpha-D-gala | ChEBI | | alpha-D-Galacturonosyl-(1->4)-alpha-D-galacturonosyl-(1->4)-alpha-D-galactnuronic acid | ChEBI | | Pectin trisaccharide | ChEBI | | Trigalacturonic acid | ChEBI | | a-D-GalA-(1->4)-a-D-gala-(1->4)-a-D-gala | Generator | | Α-D-gala-(1->4)-α-D-gala-(1->4)-α-D-gala | Generator | | a-D-Galacturonosyl-(1->4)-a-D-galacturonosyl-(1->4)-a-D-galactnuronate | Generator | | a-D-Galacturonosyl-(1->4)-a-D-galacturonosyl-(1->4)-a-D-galactnuronic acid | Generator | | alpha-D-Galacturonosyl-(1->4)-alpha-D-galacturonosyl-(1->4)-alpha-D-galactnuronate | Generator | | Α-D-galacturonosyl-(1->4)-α-D-galacturonosyl-(1->4)-α-D-galactnuronate | Generator | | Α-D-galacturonosyl-(1->4)-α-D-galacturonosyl-(1->4)-α-D-galactnuronic acid | Generator | | Trigalacturonate | Generator | | Pectate | Generator | | alpha-GalA-gala-gala | MeSH | | GalA-gala-gala | MeSH | | GalA-(1-4)-gala-(1-4)-gala | MeSH | | O-Galactopyranosyluronic acid-(1-4)-O-galactopyranosyluronic acid-(1-4)-galactopyranosyluronic acid | MeSH | | beta-GalA-gala-gala | MeSH | | a-D-GalpA-(1->4)-a-D-galpa-(1->4)-a-D-galpa | Generator | | α-D-galpa-(1->4)-α-D-galpa-(1->4)-α-D-galpa | Generator | | (1,4-alpha-D-Galacturonide)n | biospider | | (1,4-alpha-D-Galacturonosyl)n | biospider | | alpha-D-Polygalacturonic acid | biospider | | alpha-delta-Galactopyranuronic acid | HMDB | | alpha-delta-Galacturonic acid | HMDB | | alpha-delta-Polygalacturonic acid | HMDB | | Calcium pectate | HMDB | | Calcium polygalacturonate | HMDB | | D-Galacturonan | HMDB | | delta-Galacturonan | HMDB | | delta-Galacturonate | HMDB | | delta-Galacturonic acid | HMDB | | Galacturonan | HMDB | | Galacturonate | HMDB | | Galacturonic acid, homopolymer | biospider | | Pectinic acid | db_source | | Poly(1,4-alpha-D-galacturonate) | biospider | | Poly(1,4-alpha-D-galacturonate)(n) | biospider | | Poly(1,4-alpha-delta-galacturonate) | HMDB | | Polygalacturonic acid | biospider | | Sodium pectate | HMDB | | Sulfated polygalacturonic acid | HMDB |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C18H26O19 |
|---|
| IUPAC name | (2S,3R,4S,5R,6S)-6-{[(2S,3R,4R,5R,6S)-2-carboxy-6-{[(2S,3R,4R,5R,6S)-2-carboxy-4,5,6-trihydroxyoxan-3-yl]oxy}-4,5-dihydroxyoxan-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid |
|---|
| InChI Identifier | InChI=1S/C18H26O19/c19-1-2(20)10(13(26)27)36-17(6(1)24)35-9-4(22)7(25)18(37-12(9)15(30)31)34-8-3(21)5(23)16(32)33-11(8)14(28)29/h1-12,16-25,32H,(H,26,27)(H,28,29)(H,30,31)/t1-,2+,3+,4+,5+,6+,7+,8+,9+,10-,11-,12-,16-,17-,18-/m0/s1 |
|---|
| InChI Key | LCLHHZYHLXDRQG-MKJFYJHKSA-N |
|---|
| Isomeric SMILES | O[C@H]1O[C@@H]([C@H](O[C@H]2O[C@@H]([C@H](O[C@H]3O[C@@H]([C@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H](O)[C@H]2O)C(O)=O)[C@H](O)[C@H]1O)C(O)=O |
|---|
| Average Molecular Weight | 546.3876 |
|---|
| Monoisotopic Molecular Weight | 546.10682865 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as oligosaccharides. These are carbohydrates made up of 3 to 10 monosaccharide units linked to each other through glycosidic bonds. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organooxygen compounds |
|---|
| Sub Class | Carbohydrates and carbohydrate conjugates |
|---|
| Direct Parent | Oligosaccharides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Oligosaccharide
- 1-o-glucuronide
- O-glucuronide
- Glucuronic acid or derivatives
- Glycosyl compound
- O-glycosyl compound
- Tricarboxylic acid or derivatives
- Beta-hydroxy acid
- Hydroxy acid
- Pyran
- Oxane
- Hemiacetal
- Secondary alcohol
- Organoheterocyclic compound
- Acetal
- Oxacycle
- Carboxylic acid
- Carboxylic acid derivative
- Polyol
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Alcohol
- Aliphatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aliphatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Ontology | No ontology term |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Solid | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | Not Available | |
|---|
| Melting Point | Not Available | |
|---|
| Boiling Point | Not Available | |
|---|
| Experimental Water Solubility | Not Available | |
|---|
| Experimental logP | Not Available | |
|---|
| Experimental pKa | Not Available | |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | Not Available | |
|---|
| Optical Rotation | Not Available | |
|---|
| Spectroscopic UV Data | Not Available | |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | Not Available |
|---|
| External Links |
|---|
| ChemSpider ID | 393411 |
|---|
| ChEMBL ID | Not Available |
|---|
| KEGG Compound ID | C00470 |
|---|
| Pubchem Compound ID | 445929 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | Not Available |
|---|
| Phenol-Explorer ID | Not Available |
|---|
| DrugBank ID | DB03511 |
|---|
| HMDB ID | HMDB03363 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | NXB95-A:NXB95-A |
|---|
| EAFUS ID | 2882 |
|---|
| Dr. Duke ID | PECTIC-ACID|PECTIN|PECTINS|POLYGALACTURONIC-ACID|POLYGALACTURONATE |
|---|
| BIGG ID | Not Available |
|---|
| KNApSAcK ID | Not Available |
|---|
| HET ID | ADA |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | Not Available |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Pectic_acid |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Anti-atheromic | 38070 | An agent that prevents or reduces the formation of atheromas (plaques) in blood vessels, thereby lowering the risk of cardiovascular disease. It inhibits the accumulation of lipids and inflammatory cells in the arterial wall, commonly used in managing atherosclerosis, hyperlipidemia, and preventing heart attacks and strokes. | DUKE | | Anti bacterial | 33282 | An agent that inhibits the growth of or destroys bacteria, playing a crucial role in preventing and treating infections. Therapeutically, it is used to combat bacterial infections, with key medical applications including treating pneumonia, tuberculosis, and skin infections, as well as preventing surgical site infections and sepsis. | DUKE | | Anti-diabetic | 52217 | An agent that regulates blood sugar levels, enhancing insulin sensitivity or secretion. Therapeutically, it's used to manage diabetes, reducing symptoms and complications, and commonly prescribed to treat type 1 and 2 diabetes, as well as gestational diabetes. | DUKE | | Anti-diarrheic | 55323 | An agent that reduces the frequency and severity of diarrhea, commonly used to manage gastrointestinal disorders, such as irritable bowel syndrome, and to treat infectious diarrhea, by slowing bowel movements and increasing water absorption. | DUKE | | Anti enteritic | | An anti-inflammatory agent that relieves intestinal swelling, reducing enteritis symptoms. Its biological role is to mitigate intestinal inflammation, and its therapeutic applications include treating gastrointestinal disorders, such as irritable bowel syndrome. Key medical uses include managing enteritis, colitis, and other inflammatory bowel diseases. | DUKE | | Anti gallstone | | An agent that prevents the formation of gallstones, reducing the risk of gallbladder disease. Therapeutically, it helps maintain cholesterol balance and bile flow, commonly used to manage gallstone prevention and treatment, and alleviate related symptoms. | DUKE | | Anti-gastritic | | An agent that reduces stomach inflammation, protecting the gastric lining and relieving symptoms of gastritis, commonly used in managing ulcers, acid reflux, and gastrointestinal disorders. | DUKE | | Anti-lithic | | An agent that prevents the formation of calculi (kidney stones) or promotes their dissolution, playing a key role in urology. Its therapeutic applications include managing kidney stone disease, nephrolithiasis, and urinary tract disorders, helping to alleviate pain and prevent complications. | DUKE | | Anti metastatic | 35610 | An agent that inhibits cancer cell spread, reducing tumor metastasis. It plays a biological role in blocking cell migration and invasion, and has therapeutic applications in cancer treatment. Key medical uses include preventing cancer recurrence and improving survival rates in patients with various types of cancer. | DUKE | | Anti-mutagenic | | An agent that interferes with the mutagenicity of a substance, preventing DNA damage and mutations. Its biological role is to protect cells from genetic alterations, and it has therapeutic applications in cancer prevention and treatment, as well as key medical uses in reducing the risk of genetic disorders and birth defects. | DUKE | | Anti-obesity | 52217 | An agent that reduces body weight, commonly used in managing obesity and related disorders, by regulating appetite, metabolism, and fat storage, with therapeutic applications in preventing chronic diseases such as diabetes and cardiovascular disease. | DUKE | | Antitumor | 35610 | An agent that inhibits tumor growth and proliferation, playing a crucial role in cancer treatment. Therapeutically, antitumors are used to manage various types of cancer, including chemotherapy, targeted therapy, and immunotherapy, helping to reduce tumor size, prevent metastasis, and improve patient outcomes. | DUKE | | Anti-tussive | 52217 | An agent that suppresses coughing, reducing the frequency and severity of coughs. It works by targeting the brain's cough center, providing therapeutic relief for dry, irritating coughs. Key medical uses include managing coughs associated with colds, flu, and other respiratory conditions. | DUKE | | Anti ulcer | 49201 | An agent that reduces stomach acid and protects the mucous lining, preventing ulcer formation. It is used to treat conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome, promoting healing and relieving symptoms. | DUKE | | Cancer preventive | 35610 | An agent that inhibits the development and progression of cancer, reducing tumor formation and growth. It plays a biological role in blocking carcinogenic pathways, and has therapeutic applications in chemoprevention. Key medical uses include reducing the risk of cancer in high-risk individuals and preventing cancer recurrence. | DUKE | | Chemopreventive | 35610 | An agent that prevents or delays the development of cancer, reducing the risk of tumor formation and progression. It plays a biological role in inhibiting carcinogenesis, and has therapeutic applications in cancer prevention, with key medical uses including reducing the risk of colorectal, breast, and prostate cancers. | DUKE | | Demulcent | | An agent that forms a soothing film over a mucous membrane, relieving minor pain and inflammation, commonly used to protect and calm irritated tissues in the throat, mouth, and digestive tract. | DUKE | | Fungicide | 24127 | An agent that kills or inhibits the growth of fungi, playing a biological role in preventing fungal infections. Therapeutically, it is used to treat fungal diseases, with key medical applications including athlete's foot, ringworm, and candidiasis, as well as agricultural uses to protect crops from fungal damage. | DUKE | | Hemostat | | An agent that controls bleeding, playing a biological role in blood coagulation. Therapeutically, it promotes clot formation, and its key medical uses include treating wounds, surgical bleeding, and hemorrhages, helping to stabilize patients and prevent excessive blood loss. | DUKE | | Hypocholesterolemic | | An agent that lowers cholesterol levels in the blood, playing a crucial role in preventing cardiovascular disease. Therapeutically, it is used to manage hyperlipidemia and reduce the risk of heart disease, with key medical applications including the treatment of high cholesterol, atherosclerosis, and coronary artery disease. | DUKE | | Hypoglycemic | 35526 | An agent that lowers blood glucose levels, playing a crucial role in glucose metabolism. Therapeutically, it is used to manage diabetes and insulin resistance, with key medical applications in treating type 1 and 2 diabetes, and preventing diabetic complications. | DUKE | | Peristaltic | | An agent that stimulates peristalsis, promoting muscle contractions in the digestive tract to move food through the system, aiding digestion and bowel movements, with therapeutic applications in treating constipation, gastrointestinal disorders, and post-surgical bowel obstruction. | DUKE | | Pesticide | 25944 | An agent that kills or repels pests, playing a biological role in controlling insect, weed, and fungal populations. Therapeutically, pesticides have limited applications, but some are used to treat ectoparasitic infestations, such as lice and scabies. Key medical uses include topical treatments for head lice and scabies, highlighting their role in managing parasitic infections. | DUKE |
|
|---|
| Enzymes | | Name | Gene Name | UniProt ID |
|---|
| UDP-glucuronosyltransferase 2B4 | UGT2B4 | P06133 | | UDP-glucuronosyltransferase 1-4 | UGT1A4 | P22310 | | UDP-glucuronosyltransferase 2B7 | UGT2B7 | P16662 | | UDP-glucuronosyltransferase 1-1 | UGT1A1 | P22309 | | UDP-glucuronosyltransferase 1-9 | UGT1A9 | O60656 | | UDP-glucuronosyltransferase 1-6 | UGT1A6 | P19224 |
|
|---|
| Pathways | Not Available |
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | Not Available |
|---|
| Files |
|---|
| MSDS | show |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004).
|
|---|